BioSpace News Archive

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA®, Merck’s anti-PD-1 therapy, has been approved by the China National Drug Administration (CNDA) for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

MAXIMUS will issue a press release with its financial results for the three and nine months ended June 30, 2018, at 6:30 a.m. ET on Thursday, August 9, 2018, and will host a conference call the same day at 9:00 a.m. ET.

In letter to authors of the Consensus Statement on Improving Prior Authorization, CAQH CORE highlights areas of agreement, opportunities to address burdens on healthcare providers, health plans and patients

Pandion Therapeutics, Inc. announced that Nancy Stagliano, PhD will be joining its board of directors as independent director.

Winners will be Announced by Committee of Distinguished Scientific Leaders on October 25, 2018 at the Prix Galien USA Awards Ceremony

CureCervicalCancer (CCC) today announced they are just weeks away from reaching a major milestone of 100,000 women screened.

Magnolia Health announced that it will be hosting a city-wide health fair on Sept. 15 in conjunction with Mayor Lumumba’s Task Force for a Healthier Jackson’s Voices for Health Gospel Choir Competition.

There’s a huge investment opportunity unfolding right now, and it’s going largely unnoticed.

CRI is a new parameter for rapid, noninvasive indication of hemodynamic status

Partnership will educate fans and the wider community about the benefits of dental lasers